{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T06:44:45Z","timestamp":1774075485757,"version":"3.50.1"},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,3,15]]},"DOI":"10.2169\/internalmedicine.5503-25","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T22:07:24Z","timestamp":1754518044000},"page":"867-872","source":"Crossref","is-referenced-by-count":1,"title":["Progressive Multifocal Leukoencephalopathy Initially Considered as Central Nervous System Involvement of Post-Transplant Lymphoproliferative Disorder: The Critical Role of Contrast Enhancement on Magnetic Resonance Imaging"],"prefix":"10.2169","volume":"65","author":[{"given":"Wataru","family":"Komaba","sequence":"first","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keijiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimitsu","family":"Ueki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hiroshima","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Sumi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pathology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 199: 837-846, 2009.","DOI":"10.1086\/597126"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol 17: 37-51, 2021.","DOI":"10.1038\/s41582-020-00427-y"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kartau M, Verkkoniemi-Ahola A, Paetau A, et al. The incidence and predisposing factors of John Cunningham virus-induced progressive multifocal leukoencephalopathy in Southern Finland: a population-based study. Open Forum Infect Dis 6: ofz024, 2019.","DOI":"10.1093\/ofid\/ofz024"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Joly M, Conte C, Cazanave C, et al. Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions. Brain 146: 349-358, 2023.","DOI":"10.1093\/brain\/awac237"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Naik S, Riches M, Hari P, et al. Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study. Transpl Infect Dis 21: e13145, 2019.","DOI":"10.1111\/tid.13145"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Garc\u00eda-Cadenas I, Y\u00e1\u00f1ez L, Jarque I, et al.; Spanish group of blood and marrow transplantation (GETH). Frequency, characteristics, and outcome of PTLD after allo-SCT: a multicenter study from the Spanish group of blood and marrow transplantation (GETH). Eur J Haematol 102: 465-471, 2019.","DOI":"10.1111\/ejh.13226"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Buell JF, Gross TG, Hanaway MJ, et al. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement. Transplant Proc 37: 954-955, 2005.","DOI":"10.1016\/j.transproceed.2004.12.130"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Balaguer-Rosello A, Pi\u00f1ana JL, Bataller L, et al. Central nervous system involvement in Epstein-Barr virus-related post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation. Transplant Cell Ther 27: 261.e1-261.e7, 2021.","DOI":"10.1016\/j.jtct.2020.12.019"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med 378: 549-562, 2018.","DOI":"10.1056\/NEJMra1702693"},{"key":"10","doi-asserted-by":"publisher","unstructured":"11. Kempf C, Tinguely M, Rushing EJ. Posttransplant lymphoproliferative disorder of the central nervous system. Pathobiology 80: 310-318, 2013.","DOI":"10.1159\/000347225"},{"key":"11","doi-asserted-by":"publisher","unstructured":"12. Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section. Neurology 80: 1430-1438, 2013.","DOI":"10.1212\/WNL.0b013e31828c2fa1"},{"key":"12","unstructured":"13. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. International Agency for Research on Cancer, Lyon, 2017: 453-462."},{"key":"13","doi-asserted-by":"crossref","unstructured":"14. Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep 8: 173-183, 2013.","DOI":"10.1007\/s11899-013-0162-5"},{"key":"14","doi-asserted-by":"publisher","unstructured":"15. Cavaliere R, Petroni G, Lopes MB, Schiff D; International Primary Central Nervous System Lymphoma Collaborative Group. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group report. Cancer 116: 863-870, 2010.","DOI":"10.1002\/cncr.24834"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Wijburg MT, Kleerekooper I, Lissenberg-Witte BI, et al. Association of progressive multifocal leukoencephalopathy lesion volume with JC virus polymerase chain reaction results in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. JAMA Neurol 75: 827-833, 2018.","DOI":"10.1001\/jamaneurol.2018.0094"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17. Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 33: 484-486, 1995.","DOI":"10.1128\/jcm.33.2.484-486.1995"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18. Evens AM, Choquet S, Kroll-Desrosiers AR, et al. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era. Am J Transplant 13: 1512-1522, 2013.","DOI":"10.1111\/ajt.12211"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19. Bennett CL, Focosi D, Socal MP, et al. Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions. Lancet Haematol 8: e593-e604, 2021.","DOI":"10.1016\/S2352-3026(21)00167-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20. Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53: 1840-1849, 2009.","DOI":"10.1128\/AAC.01614-08"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21. Clifford DB, Nath A, Cinque P, et al. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol 19: 351-358, 2013.","DOI":"10.1007\/s13365-013-0173-y"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22. Maginnis MS, Haley SA, Gee GV, Atwood WJ. Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection. J Virol 84: 9677-9684, 2010.","DOI":"10.1128\/JVI.00978-10"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23. Shah R, Bag AK, Chapman PR, Cur\u00e9 JK. Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 65: 431-439, 2010.","DOI":"10.1016\/j.crad.2010.03.001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24. White ML, Moore DW, Zhang Y, Mark KD, Greiner TC, Bierman PJ. Primary central nervous system post-transplant lymphoproliferative disorders: the spectrum of imaging appearances and differential. Insights Imaging 10: 46, 2019.","DOI":"10.1186\/s13244-019-0726-6"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/6\/65_5503-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T03:33:13Z","timestamp":1774063993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/6\/65_5503-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5503-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"article-number":"5503-25"}}